<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Statement of Operations for the Twelve Months Ended June 30, 2000
and the Consolidated Statement of Financial Position at June 30, 2000 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUN-30-2000
<PERIOD-START> JUL-01-1999
<PERIOD-END> JUN-30-2000
<CASH> 964,502
<SECURITIES> 541,140
<RECEIVABLES> 382,558
<ALLOWANCES> 3,965
<INVENTORY> 157,827
<CURRENT-ASSETS> 2,125,527
<PP&E> 520,227
<DEPRECIATION> 185,372
<TOTAL-ASSETS> 3,083,315
<CURRENT-LIABILITIES> 646,500
<BONDS> 0
0
0
<COMMON> 2,680
<OTHER-SE> 2,217,812
<TOTAL-LIABILITY-AND-EQUITY> 3,083,315
<SALES> 1,371,035
<TOTAL-REVENUES> 1,371,035
<CGS> 609,054
<TOTAL-COSTS> 609,054
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 3,146
<INTEREST-EXPENSE> 3,501
<INCOME-PRETAX> 136,108
<INCOME-TAX> 40,612
<INCOME-CONTINUING> 95,496
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 95,496
<EPS-BASIC> 0<F1>
<EPS-DILUTED> 0<F2>
<FN>
<F1>Basic earnings per share - PE Biosystems Group .90<F3>
Basic loss per share - Celera Genomics Group (1.73)<F3>
<F2>Diluted earnings per share - PE Biosystems Group .86<F3>
Diluted loss per share - Celera Genomics Group (1.73)<F3>
<F3>PE Biosystems Group and Celera Genomics Group per share data reflect two-for-one stock splits effective February 2000. Financial
data schedules for periods prior to this effective date have not been restated to reflect these splits.
</FN>
</TABLE>
